The authors showed that positive ctDNA liquid rebiopsies in ALK-mutated NSCLC are indicative of a more aggressive disease, which is a common observation in extracranial but rare in CNS-only progression. This evidence concerns the gene ALK and non-small cell lung carcinoma.